2004
DOI: 10.1016/j.abb.2003.10.002
|View full text |Cite
|
Sign up to set email alerts
|

Alternative splicing of the human MUC2 gene

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
9
0

Year Published

2004
2004
2020
2020

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 12 publications
(10 citation statements)
references
References 43 publications
1
9
0
Order By: Relevance
“…In MUC2 -MS5 and -MS8 (introns 26 and 40, respectively) we also found several canonical CACGT-binding sites for the MYC family of oncogenic transcription factors. Furthermore, alternatively-spliced transcript variants of MUC2 that include variations in intron 30 and exon 30 have been described previously [32]. Therefore, our data suggest that these minisatellites may contain sequences that are involved in two major regulatory mechanisms for MUC2 : transcriptional control of MUC2 and alternative splicing of MUC2 transcripts.…”
Section: Discussionsupporting
confidence: 67%
“…In MUC2 -MS5 and -MS8 (introns 26 and 40, respectively) we also found several canonical CACGT-binding sites for the MYC family of oncogenic transcription factors. Furthermore, alternatively-spliced transcript variants of MUC2 that include variations in intron 30 and exon 30 have been described previously [32]. Therefore, our data suggest that these minisatellites may contain sequences that are involved in two major regulatory mechanisms for MUC2 : transcriptional control of MUC2 and alternative splicing of MUC2 transcripts.…”
Section: Discussionsupporting
confidence: 67%
“…While the repression and overexpression that we produced could have been achieved by using combinations of several siRNAs or cDNAs, these methods are limited. For example, in various tumor cell lines, alternatively spliced variants of oncogenic proteins have been observed (21,37,66,67). Alternatively spliced ErbB2 proteins have been shown to mediate effects that differ from those of the full-length receptor protein (2,62,82).…”
Section: Discussionmentioning
confidence: 99%
“…In addition, analysis of MUC2 in the LS174T derived HM7 colon cancer cell line led to the identification of a transcript variant that lacked the second PTS domain [20]. The presence of this highly polymorphic PTS VNTR (variable number of tandem repeats) has inhibited the resolution of the full-length mRNA, as well as the functional annotation of the complete DNA sequence in many species, including mouse and human [4], [9], [10].…”
Section: Introductionmentioning
confidence: 99%